Fluvoxamine · Fluvoxamine Maleate, TEV-56286

What is Fluvoxamine?

Fluvoxamine is a selective serotonin reuptake inhibitor that blocks serotonin reuptake at the presynaptic neuronal membrane, increasing serotonin levels in the synaptic cleft.

Summary written with AI from the sources listed at the end of this page.

At a glance

Also known as

Fluvoxamine Maleate, TEV-56286

Drug type

Small molecule

Targets

serotonin transporter (SLC6A4)

Mechanism

Inhibitor of serotonin transporter (SLC6A4)

Pathways

serotonergic transmission

Therapy area

Gastroenterology

Developer

Solvay

In trials of

ABVX, CORT, TEVA

FDA status

Approved as Fluvoxamine Maleate (December 5, 1994), NDA020243 · FDA label

✅ FDA-approved uses

• Obsessive compulsive disorder

From the indications section of the FDA label (version of Apr 23, 2026). Read the full label for the exact wording, limitations and safety information.

🧪 Clinical trials

Trials of the companies BioRadar tracks, from ClinicalTrials.gov, most advanced phase first.

Conditions studied

Antipsychotic Induced Weight GainHealthyHealthy VolunteersNon-alcoholic Steatohepatitis (NASH)

Sources

• FDA label (DailyMed)
• FDA label Fluvoxamine Maleate (2026-04-23), indications
• NCI Thesaurus
• ClinicalTrials.gov NCT05121714
• ClinicalTrials.gov NCT05532358
• ClinicalTrials.gov NCT05532358

Updated Oct 3, 2026.